Literature DB >> 20440284

Gene-expression-based prognostic assays for breast cancer.

Chungyeul Kim1, Soonmyung Paik.   

Abstract

Several gene-expression-based reference laboratory tests are now available for prognostication of patients diagnosed with breast cancer. For clinical oncologists, it is important to understand the clinical contexts for which these assays were developed in order to use them properly. This Review is aimed at providing a conceptual and technical overview of the steps involved in the development of gene-expression profiling-based prognostic assays. MammaPrint and Oncotype DX, two widely utilized assays, are compared with respect to differences in the clinical contexts for their development, technologies used, and clinical utilities with the aim of providing a guide to clinical oncologists for utilization of these assays.

Entities:  

Mesh：

Year:  2010        PMID： 20440284     DOI： 10.1038/nrclinonc.2010.61

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


  35 in total

1.  Direct multiplexed measurement of gene expression with color-coded probe pairs.

Authors:  Gary K Geiss; Roger E Bumgarner; Brian Birditt; Timothy Dahl; Naeem Dowidar; Dwayne L Dunaway; H Perry Fell; Sean Ferree; Renee D George; Tammy Grogan; Jeffrey J James; Malini Maysuria; Jeffrey D Mitton; Paola Oliveri; Jennifer L Osborn; Tao Peng; Amber L Ratcliffe; Philippa J Webster; Eric H Davidson; Leroy Hood; Krassen Dimitrov
Journal:  Nat Biotechnol       Date:  2008-02-17       Impact factor: 54.908

2.  Quantitative monitoring of gene expression patterns with a complementary DNA microarray.

Authors:  M Schena; D Shalon; R W Davis; P O Brown
Journal:  Science       Date:  1995-10-20       Impact factor: 47.728

3.  Molecular portraits of human breast tumours.

Authors:  C M Perou; T Sørlie; M B Eisen; M van de Rijn; S S Jeffrey; C A Rees; J R Pollack; D T Ross; H Johnsen; L A Akslen; O Fluge; A Pergamenschikov; C Williams; S X Zhu; P E Lønning; A L Børresen-Dale; P O Brown; D Botstein
Journal:  Nature       Date:  2000-08-17       Impact factor: 49.962

4.  The 70-gene signature as a response predictor for neoadjuvant chemotherapy in breast cancer.

Authors:  Marieke E Straver; Annuska M Glas; Juliane Hannemann; Jelle Wesseling; Marc J van de Vijver; Emiel J Th Rutgers; Marie-Jeanne T F D Vrancken Peeters; Harm van Tinteren; Laura J Van't Veer; Sjoerd Rodenhuis
Journal:  Breast Cancer Res Treat       Date:  2009-02-13       Impact factor: 4.872

5.  Analysis of the MammaPrint breast cancer assay in a predominantly postmenopausal cohort.

Authors:  Ben S Wittner; Dennis C Sgroi; Paula D Ryan; Tako J Bruinsma; Annuska M Glas; Anitha Male; Sonika Dahiya; Karleen Habin; Rene Bernards; Daniel A Haber; Laura J Van't Veer; Sridhar Ramaswamy
Journal:  Clin Cancer Res       Date:  2008-05-15       Impact factor: 12.531

6.  Analytical validation of the Oncotype DX genomic diagnostic test for recurrence prognosis and therapeutic response prediction in node-negative, estrogen receptor-positive breast cancer.

Authors:  Maureen Cronin; Chithra Sangli; Mei-Lan Liu; Mylan Pho; Debjani Dutta; Anhthu Nguyen; Jennie Jeong; Jenny Wu; Kim Clark Langone; Drew Watson
Journal:  Clin Chem       Date:  2007-04-26       Impact factor: 8.327

7.  The 70-gene prognosis signature predicts early metastasis in breast cancer patients between 55 and 70 years of age.

Authors:  S Mook; M K Schmidt; B Weigelt; B Kreike; I Eekhout; M J van de Vijver; A M Glas; A Floore; E J T Rutgers; L J van 't Veer
Journal:  Ann Oncol       Date:  2009-10-13       Impact factor: 32.976

8.  Supervised risk predictor of breast cancer based on intrinsic subtypes.

Authors:  Joel S Parker; Michael Mullins; Maggie C U Cheang; Samuel Leung; David Voduc; Tammi Vickery; Sherri Davies; Christiane Fauron; Xiaping He; Zhiyuan Hu; John F Quackenbush; Inge J Stijleman; Juan Palazzo; J S Marron; Andrew B Nobel; Elaine Mardis; Torsten O Nielsen; Matthew J Ellis; Charles M Perou; Philip S Bernard
Journal:  J Clin Oncol       Date:  2009-02-09       Impact factor: 44.544

Review 9.  Commercialized multigene predictors of clinical outcome for breast cancer.

Authors:  Jeffrey S Ross; Christos Hatzis; W Fraser Symmans; Lajos Pusztai; Gabriel N Hortobágyi
Journal:  Oncologist       Date:  2008-05

10.  A population-based study of tumor gene expression and risk of breast cancer death among lymph node-negative patients.

Authors:  Laurel A Habel; Steven Shak; Marlena K Jacobs; Angela Capra; Claire Alexander; Mylan Pho; Joffre Baker; Michael Walker; Drew Watson; James Hackett; Noelle T Blick; Deborah Greenberg; Louis Fehrenbacher; Bryan Langholz; Charles P Quesenberry
Journal:  Breast Cancer Res       Date:  2006-05-31       Impact factor: 6.466
View more
  47 in total

Review 1.  Practical implications of gene-expression-based assays for breast oncologists.

Authors:  Aleix Prat; Matthew J Ellis; Charles M Perou
Journal:  Nat Rev Clin Oncol       Date:  2011-12-06       Impact factor: 66.675

Review 2.  RNA-Seq and human complex diseases: recent accomplishments and future perspectives.

Authors:  Valerio Costa; Marianna Aprile; Roberta Esposito; Alfredo Ciccodicola
Journal:  Eur J Hum Genet       Date:  2012-06-27       Impact factor: 4.246

3.  Prognostic significance of gene-specific promoter hypermethylation in breast cancer patients.

Authors:  Yoon Hee Cho; Jing Shen; Marilie D Gammon; Yu-Jing Zhang; Qiao Wang; Karina Gonzalez; Xinran Xu; Patrick T Bradshaw; Susan L Teitelbaum; Gail Garbowski; Hanina Hibshoosh; Alfred I Neugut; Jia Chen; Regina M Santella
Journal:  Breast Cancer Res Treat       Date:  2011-08-12       Impact factor: 4.872

Review 4.  Biomarkers and sustainable innovation in cardiovascular drug development: lessons from near and far afield.

Authors:  Russell M Medford; T Forcht Dagi; Robert S Rosenson; Margaret K Offermann
Journal:  Curr Atheroscler Rep       Date:  2013-05       Impact factor: 5.113

5.  Downregulation of DYRK2 can be a predictor of recurrence in early stage breast cancer.

Authors:  Yasuko Enomoto; Shin-ichi Yamashita; Yasuteru Yoshinaga; Yasuyoshi Fukami; So Miyahara; Kazuki Nabeshima; Akinori Iwasaki
Journal:  Tumour Biol       Date:  2014-08-06

6.  Identification of predictive markers of cytarabine response in AML by integrative analysis of gene-expression profiles with multiple phenotypes.

Authors:  Jatinder K Lamba; Kristine R Crews; Stanley B Pounds; Xueyuan Cao; Varsha Gandhi; William Plunkett; Bassem I Razzouk; Vishal Lamba; Sharyn D Baker; Susana C Raimondi; Dario Campana; Ching-Hon Pui; James R Downing; Jeffrey E Rubnitz; Raul C Ribeiro
Journal:  Pharmacogenomics       Date:  2011-03       Impact factor: 2.533

7.  Neoadjuvant endocrine treatment for breast cancer: from bedside to bench and back again?

Authors:  R R Saleh; N Bouganim; J Hilton; A Arnaout; M Clemons
Journal:  Curr Oncol       Date:  2014-02       Impact factor: 3.677

Review 8.  From drug discovery to biomarker-driven clinical trials in lymphoma.

Authors:  Anas Younes; Donald A Berry
Journal:  Nat Rev Clin Oncol       Date:  2012-09-11       Impact factor: 66.675

Review 9.  Nervous system regulation of the cancer genome.

Authors:  Steven W Cole
Journal:  Brain Behav Immun       Date:  2012-12-01       Impact factor: 7.217

Review 10.  Breast cancer classification and prognostication through diverse systems along with recent emerging findings in this respect; the dawn of new perspectives in the clinical applications.

Authors:  Vida Pourteimoor; Samira Mohammadi-Yeganeh; Mahdi Paryan
Journal:  Tumour Biol       Date:  2016-09-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.